Myhep LVIR (ledipasvir 90mg & Sofosbuvir 400mg) View larger

Myhep LVIR (ledipasvir 90mg/Sofosbuvir 400mg)

New product

$209.00

$209.00 per 28 Tablets

Indications & Dosage

Myhep Lvir, also known as Hepcinat-LP, Hepcvilr L” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Myhep Lvir combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C.

Myhep Lvir is a generic prescription medicine from Mylan, which is one of the biggest pharmaceutical company in India.

Myhep LVIR Dosage:

For the treatment of chronic hepatitis C infection.
For the treatment of chronic hepatitis C virus (HCV) genotype 1 infection.
Oral dosage
Treatment-naive Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks; however, an 8-week treatment duration can be considered for those patients with a baseline hepatitis C virus RNA less than 6 million international units/mL. Recommendation includes patients coinfected with HIV.

Treatment-naive Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Alternatively, treatment duration may be reduced to 12 weeks if ledipasvir; sofosbuvir is administered in combination with ribavirin. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin (600 mg PO once daily) for 12 weeks. Ribavirin must be administered with food, and if tolerated, the dose may be increased as follows: if less than 75 kg give 500 mg PO twice daily; if 75 kg or more give 600 mg PO twice daily. Consider decreasing ribavirin dose for abnormal hemoglobin. Recommendation includes patients coinfected with HIV. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive Children and Adolescents 12 to 17 years without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive Children younger than 12 years weighing at least 35 kg without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotypes 5 or 6 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with weight-based ribavirin for 12 weeks as a preferred regimen.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotype 4 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Myhep LVIR Side Effects:

Hepatitis B virus reactivation: Before starting treatment with Myhep LVIR, your healthcare provider will do blood tests to check for hepatitis B virus infection. If you have ever had hepatitis B virus infection, the hepatitis B virus could become active again during or after treatment of hepatitis C virus with Myhep LVIR. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure and death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop taking 

Myhep LVIR PI

For more Prescribing information，please ask for “Prescribing Information” from our customer supporter.

Additional Info

Package Quantity28
WarningsDon't take the drug without consulting a qualified doctor or physician
Suggested useFollow the doctor's advice
IngredientsMyhep LVIR is used to treat chronic hepatitis C in adults with HCV genotype 1, 4, 5, or 6.
Delivery & Returns7-14 days

Reviews

Grade 
2019-04-27 13:09:12
Thank you!!!

Thank you very much I just received my package today I will be able to start my treatment today and with God’s will I will see a better tomorrow
Thank you!!!

    Grade 
    2019-03-17 04:31:37
    Excelent

    Three months after my dad finished the treatment and the virus is undetectable!!

      Grade 
      2018-06-29 02:03:29
      Good service

      I got the medicine in time. The service is very good. My dad has the treatment for a month and so far all is looking good. Thank you.

        Grade 
        2018-01-11 01:29:54
        God bless me

        I took Myhep Lvir for 12 weeks. Out of those 12 weeks there were only 2 days that I really suffered with terrible headaches. My doctor suggest me to drink plenty of water After that.no more headaches. After treatment viral load zero. I am still waiting now for the 3 month test. God bless me!!

        • 1 out of 1 people found this review useful.
        Grade 
        2017-12-08 09:18:34
        Good

        My friend recommended this online pharmacy to me. now 3 days to go on a 12 week treatment plan for this Indian generic Harvoni. Undetectable after 4th week Unbelievable. No side affects whatsoever. Hope poor people can find this online pharmacy.

        • 1 out of 1 people found this review useful.
        Grade 
        2017-12-04 03:27:04
        I am truly happy!!!!

        After took this Indian "Harvoni", I start to wait for the day to cure. Day 19 just received my first viral count it is undetectable. Thank you Lord for Myhep LVIR. I still experience some fatigue and insomnia but it does not bother me at all. I have about 8 and and a half more weeks to go my doctor said I have to finish the treatments. I am truly happy!!!!

          Write your review!

          Write a review

          Myhep LVIR (ledipasvir 90mg/Sofosbuvir 400mg)

          Myhep LVIR (ledipasvir 90mg/Sofosbuvir 400mg)

          Ledipasvir 90mg/Sofosbuvir 400mg

          Accessories

          30 other products in the same category:

          Related products

          SiteLock